Pulmocide Alternatives & Competitors
12 companies similar to Pulmocide — Developing best-in-class inhaled medicines for targeted treatment of life-threat...
Companies similar to Pulmocide
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...
Pearl Therapeutics
Developing innovative combination therapies for respiratory health, enhancing safety, effi...
Corus Pharma
Driving advancements in respiratory health with innovative inhalable treatments.
Rival Readout
Competing with Pulmocide? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Implicit Bioscience
Implicit Bioscience is developing groundbreaking immunotherapy treatments for serious, oft...
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
NeRRe Therapeutics Ltd
Developing a breakthrough treatment for the disabling chronic cough associated with idiopa...
Neurotrope Inc.
Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...
Neumora
Pioneering a new era of medicines for brain diseases
Breath Therapeutics
Since 1906 our mission is innovating Cure & Care to make patients’ lives better.
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
About Pulmocide
Pulmocide, a biopharmaceutical company founded in 2013 and based in the United Kingdom, is pioneering the development of inhaled medicines for the targeted treatment of life-threatening respiratory diseases. Their core focus is on serious respiratory fungal infections, particularly pulmonary aspergillosis, which pose s...
Development of Novel Inhaled Medicines, Clinical Development of Opelconazole, Treatment for Invasive Pulmonary Aspergillosis, Research on Aspergillus-related Conditions
Patients with Invasive Pulmonary Aspergillosis, Healthcare Providers, Medical Researchers, Pharmaceutical Companies
Biopharmaceuticals, Respiratory Diseases, Inhaled Medicines, Fungal Infections, Pulmonary Aspergillosis, Lung Transplant, Drug Development, Inhaled Therapies, Infectious Diseases, Clinical Development, Pharmaceutical Industry
B2B, B2G, B2B2C
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Pulmocide: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Pulmocide on 11 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.